Advanced Human Imaging Ltd (ASX: AHI) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Advanced Human Imaging Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $121.65 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 136.92 million
Earnings per share -0.069
Dividend per share N/A
Year To Date Return -29.75%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Advanced Human Imaging Ltd (ASX: AHI)
Latest News

AHI ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

About Advanced Human Imaging Ltd

A software company that has developed a software application MyFiziq Technology and App for Smart Phones. The app converts photos of the human body into 3D image known as a Personal Avatar.

Formerly MyFiziq Limited (MYQ)

AHI Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
29 Nov 2021 $0.77 $-0.09 -10.59% 725,146 $0.78 $0.80 $0.76
26 Nov 2021 $0.85 $0.00 0.00% 393,634 $0.86 $0.92 $0.84
25 Nov 2021 $0.85 $-0.12 -12.44% 1,026,546 $0.96 $0.99 $0.85
24 Nov 2021 $0.97 $-0.24 -20.00% 937,363 $1.00 $1.07 $0.90
17 Nov 2021 $1.20 $0.01 0.84% 352,192 $1.19 $1.20 $1.11
16 Nov 2021 $1.19 $-0.01 -0.83% 206,195 $1.24 $1.24 $1.15
15 Nov 2021 $1.20 $0.04 3.45% 342,768 $1.17 $1.22 $1.10
12 Nov 2021 $1.16 $0.01 0.87% 551,451 $1.16 $1.16 $1.03
11 Nov 2021 $1.15 $0.15 15.00% 850,388 $1.06 $1.18 $1.06
10 Nov 2021 $1.00 $0.13 14.86% 301,933 $0.93 $1.00 $0.89
09 Nov 2021 $0.88 $0.01 1.16% 146,167 $0.87 $0.91 $0.87
08 Nov 2021 $0.87 $-0.07 -7.53% 355,343 $0.93 $0.93 $0.86
05 Nov 2021 $0.93 $0.04 4.49% 259,866 $0.89 $0.95 $0.89
04 Nov 2021 $0.89 $-0.04 -4.32% 414,642 $0.92 $0.92 $0.87
03 Nov 2021 $0.93 $-0.01 -1.06% 594,979 $0.94 $0.95 $0.88
02 Nov 2021 $0.94 $-0.06 -6.03% 138,509 $1.00 $1.00 $0.94
01 Nov 2021 $1.00 $-0.13 -11.61% 731,413 $1.07 $1.07 $0.93

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
23 Apr 2021 Nicholas (Nick) Prosser Issued 1 $1,790,000
Issue of securities.
12 Mar 2021 Vlado Bosanac Issued 2 $3,910,000
Conversion of securities.
12 Mar 2021 Vlado Bosanac Exercise 2 $3,910,000
Conversion of securities. 12,000,000 - Performance Rights
16 Dec 2020 Michael (Mike) Melby Issued 1 $1,065,000
Issue of securities.
16 Dec 2020 Nicholas (Nick) Prosser Issued 1 $1,065,000
Issue of securities.
16 Dec 2020 Nicholas (Nick) Prosser Issued 1 $1,065,000
Issue of securities.
16 Dec 2020 Vlado Bosanac Issued 10 $10,650,000
Issue of securities. 14,000,000 - Performance Rights
As per announcement on 18/12/2020

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Vlado Bosanac FounderChief Executive OfficerExecutive DirectorExecutive Chairman Oct 2016
Mr. Bosanac, combines over 28 years of experience in capital markets, deal origination, negotiation, corporate advisory, strategy, project implementation, and private and public investment. He has a strong track record in delivering results and his skill sets will help the Company to move towards commercialisation of the MyFiziq app.
Mr Michael (Mike) Melby Non-Executive Director Oct 2017
Mr Melby brings knowledge and skills to the Board through his experience as an investment banker and private equity professional. Mr Melby has demonstrated success investing in the fitness industry. Mr Melby's experience encompasses operating leading health club brands around the world, finance and digital strategy, business development and international growth.
Mr Nicholas (Nick) Prosser Non-Executive Director Apr 2018
Mr Prosser has over 20 years of experience in the ICT sector and over 10 years as a founder, entrepreneur,and private investor. Previously he has been involved in Canberra Data Center as a founder and director.
Mr Dato Koon Poh Low Non-Executive Director Jul 2020
Dato Low has over 30 years' experience in corporate finance, capital markets and M & A. Dato Low, holds multiple offices in both private and public companies. One of which is Singapore listed IEV Holdings. His primary focus as Executive Director of IEV Holdings Limited (SGX: IEV), the Company involved in across the healthcare and wellness sector. Dato Low has been involved in capital market advisory positions across multiple jurisdictions including Australia, Singapore, Malaysia, Hong Kong and the US NASDAQ and NYSE. Dato Low has focuses in restructuring, mergers & acquisitions, and corporate transactions for over 30 years. Over the last 3 decades, he has participated in many corporate transactions in multiple industries and across international borders.
Mr Edward F Greissing Jr Non-Executive Director Feb 2021
Mr Greissing Jr. is a Strategic Advisor and Senior Fellow with the Milken Institute. Previously he was the Executive Director for the Center of Public Health at the Milken Institute. His work with global business and government leaders, investors, philanthropy, NGOs, and academic thought leaders improves health outcomes for individuals and communities everywhere. Before his time with the Milken Institute, he served as a member of the Executive Committee, Global Leadership Team, and Senior Vice President of Corporate Affairs at Sanofi. During his nearly four decades in the biopharmaceutical industry, Mr Greissing led a range of Public Affairs and Global Corporate Affairs teams, first at the Upjohn Company and Pharmacia and later with Sanofi. Previously he served as President and Chief Executive Officer of Red Line Associates, a consulting firm with clients from the biopharmaceutical, device, food service, and financial industries. Before entering the industry in 1978, Mr Greissing was on the U.S. Senate Intelligence Committee staff, served in the United States Army, and was a military policeman assigned to the Honor Detail at Fort Myer at Arlington Cemetery.
Ms Luisa Ingargiola Non-Executive Director Feb 2021
Ms Ingargiola has almost 20 years of experience in public company finance, compliance, capital markets oversight and mergers and acquisitions. She currently serves as Chief Financial Officer of a NASDAQ biotech firm and Audit Chair of several Public companies including AgEagle (NYSE: UAVS), Vision Marine (NASDAQ:VMAR) and Progress Acquisition Corporation (NASDAQ:PGRWU), a new SPAC that recently completed their IPO. She has served multiple public companies in various Officer and Director roles. Ms Ingargiola has helped guide the uplist or IPO of several companies to NASDAQ or the NYSE.
Mr Steven Richards Chief Financial OfficerCompany Secretary Sep 2019
Steven Richards Chief Financial OfficerCompany Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Mad Scientist Pty Ltd 16,900,000 14.70%
The Rain Maker Mgmt Sdn Bhd 12,393,652 10.78%
Pheakes Pty Ltd 8,700,000 7.57%
Mr Nicholas John Blair Prosser 5,510,036 4.79%
J P Morgan Nominees Australia Pty Limited 4,410,853 3.84%
Paul Di Giuseppe (The Vb Account) 3,391,864 2.95%
Citicorp Nominees Pty Limited 3,180,314 2.77%
Bnp Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 3,107,204 2.70%
Terence Stupple 2,500,000 2.17%
J15I Pte Ltd (W E F 16/06/2017) 2,466,375 2.15%
Hsbc Custody Nominees (Australia) Limited 2,116,943 1.84%
Soheila Taebi 2,100,000 1.83%
Ifm Pty Limited 2,014,959 1.75%
Fitlab Fund Management Llc 2,000,000 1.74%
BNP Paribas Noms Pty Ltd (Drp) 1,813,916 1.58%
Mr Willy Chan Foo Weng 1,665,287 1.45%
Mr John Zaccaria (The Zaccaria Share A/C) 1,500,000 1.30%
Red Leaf Securities Pty Ltd 1,200,000 1.04%
Netwealth Investments Limited (Wrap Services A/C) 1,117,167 0.97%
Mr Mohaamad Shamin Bin Mohaamad Sahafi 1,054,370 0.92%